[Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa].
Identifieur interne : 001C73 ( Ncbi/Merge ); précédent : 001C72; suivant : 001C74[Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa].
Auteurs : S. Vignes [France] ; M. Stoyanova ; E. Vasseur ; G. Haicault De La Regontais ; T. HanslikSource :
- La Revue de medecine interne [ 0248-8663 ] ; 2005.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Anti-inflammatoires (usage thérapeutique), Anti-inflammatoires non stéroïdiens (usage thérapeutique), Antigoutteux (usage thérapeutique), Colchicine (usage thérapeutique), Dapsone (usage thérapeutique), Diagnostic différentiel, Femelle, Humains, Jambe (anatomopathologie), Lymphoedème (traitement médicamenteux), Lymphoedème (étiologie), Polyartérite noueuse (), Polyartérite noueuse (diagnostic), Polyartérite noueuse (traitement médicamenteux), Prednisone (usage thérapeutique), Pronostic, Récidive, Rémission spontanée.
- MESH :
- anatomopathologie : Jambe.
- diagnostic : Polyartérite noueuse.
- traitement médicamenteux : Lymphoedème, Polyartérite noueuse.
- usage thérapeutique : Anti-inflammatoires, Anti-inflammatoires non stéroïdiens, Antigoutteux, Colchicine, Dapsone, Prednisone.
- étiologie : Lymphoedème.
- Adulte d'âge moyen, Diagnostic différentiel, Femelle, Humains, Polyartérite noueuse, Pronostic, Récidive, Rémission spontanée.
English descriptors
- KwdEn :
- Anti-Inflammatory Agents (therapeutic use), Anti-Inflammatory Agents, Non-Steroidal (therapeutic use), Colchicine (therapeutic use), Dapsone (therapeutic use), Diagnosis, Differential, Female, Gout Suppressants (therapeutic use), Humans, Leg (pathology), Lymphedema (drug therapy), Lymphedema (etiology), Middle Aged, Polyarteritis Nodosa (complications), Polyarteritis Nodosa (diagnosis), Polyarteritis Nodosa (drug therapy), Prednisone (therapeutic use), Prognosis, Recurrence, Remission, Spontaneous.
- MESH :
- chemical , therapeutic use : Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Colchicine, Dapsone, Gout Suppressants, Prednisone.
- complications : Polyarteritis Nodosa.
- diagnosis : Polyarteritis Nodosa.
- drug therapy : Lymphedema, Polyarteritis Nodosa.
- etiology : Lymphedema.
- pathology : Leg.
- Diagnosis, Differential, Female, Humans, Middle Aged, Prognosis, Recurrence, Remission, Spontaneous.
Abstract
Cutaneous periarteritis nodosa is a localized form middle-sized arteriolitis. Its main clinical features are nodules, livedo reticularis and ulcers of the lower limbs.
DOI: 10.1016/j.revmed.2004.09.019
PubMed: 15639327
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003E05
- to stream PubMed, to step Curation: 003E05
- to stream PubMed, to step Checkpoint: 003E05
Links to Exploration step
pubmed:15639327Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa].</title><author><name sortKey="Vignes, S" sort="Vignes, S" uniqKey="Vignes S" first="S" last="Vignes">S. Vignes</name><affiliation wicri:level="3"><nlm:affiliation>Unité de Lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris, France. stephane.vignes@hopital-cognacq-jay.fr </nlm:affiliation> <country xml:lang="fr">France</country><wicri:regionArea>Unité de Lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Stoyanova, M" sort="Stoyanova, M" uniqKey="Stoyanova M" first="M" last="Stoyanova">M. Stoyanova</name></author><author><name sortKey="Vasseur, E" sort="Vasseur, E" uniqKey="Vasseur E" first="E" last="Vasseur">E. Vasseur</name></author><author><name sortKey="Haicault De La Regontais, G" sort="Haicault De La Regontais, G" uniqKey="Haicault De La Regontais G" first="G" last="Haicault De La Regontais">G. Haicault De La Regontais</name></author><author><name sortKey="Hanslik, T" sort="Hanslik, T" uniqKey="Hanslik T" first="T" last="Hanslik">T. Hanslik</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15639327</idno><idno type="pmid">15639327</idno><idno type="doi">10.1016/j.revmed.2004.09.019</idno><idno type="wicri:Area/PubMed/Corpus">003E05</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003E05</idno><idno type="wicri:Area/PubMed/Curation">003E05</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003E05</idno><idno type="wicri:Area/PubMed/Checkpoint">003E05</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003E05</idno><idno type="wicri:Area/Ncbi/Merge">001C73</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa].</title><author><name sortKey="Vignes, S" sort="Vignes, S" uniqKey="Vignes S" first="S" last="Vignes">S. Vignes</name><affiliation wicri:level="3"><nlm:affiliation>Unité de Lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris, France. stephane.vignes@hopital-cognacq-jay.fr </nlm:affiliation> <country xml:lang="fr">France</country><wicri:regionArea>Unité de Lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Stoyanova, M" sort="Stoyanova, M" uniqKey="Stoyanova M" first="M" last="Stoyanova">M. Stoyanova</name></author><author><name sortKey="Vasseur, E" sort="Vasseur, E" uniqKey="Vasseur E" first="E" last="Vasseur">E. Vasseur</name></author><author><name sortKey="Haicault De La Regontais, G" sort="Haicault De La Regontais, G" uniqKey="Haicault De La Regontais G" first="G" last="Haicault De La Regontais">G. Haicault De La Regontais</name></author><author><name sortKey="Hanslik, T" sort="Hanslik, T" uniqKey="Hanslik T" first="T" last="Hanslik">T. Hanslik</name></author></analytic><series><title level="j">La Revue de medecine interne</title><idno type="ISSN">0248-8663</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Inflammatory Agents (therapeutic use)</term><term>Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)</term><term>Colchicine (therapeutic use)</term><term>Dapsone (therapeutic use)</term><term>Diagnosis, Differential</term><term>Female</term><term>Gout Suppressants (therapeutic use)</term><term>Humans</term><term>Leg (pathology)</term><term>Lymphedema (drug therapy)</term><term>Lymphedema (etiology)</term><term>Middle Aged</term><term>Polyarteritis Nodosa (complications)</term><term>Polyarteritis Nodosa (diagnosis)</term><term>Polyarteritis Nodosa (drug therapy)</term><term>Prednisone (therapeutic use)</term><term>Prognosis</term><term>Recurrence</term><term>Remission, Spontaneous</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Anti-inflammatoires (usage thérapeutique)</term><term>Anti-inflammatoires non stéroïdiens (usage thérapeutique)</term><term>Antigoutteux (usage thérapeutique)</term><term>Colchicine (usage thérapeutique)</term><term>Dapsone (usage thérapeutique)</term><term>Diagnostic différentiel</term><term>Femelle</term><term>Humains</term><term>Jambe (anatomopathologie)</term><term>Lymphoedème (traitement médicamenteux)</term><term>Lymphoedème (étiologie)</term><term>Polyartérite noueuse ()</term><term>Polyartérite noueuse (diagnostic)</term><term>Polyartérite noueuse (traitement médicamenteux)</term><term>Prednisone (usage thérapeutique)</term><term>Pronostic</term><term>Récidive</term><term>Rémission spontanée</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents</term><term>Anti-Inflammatory Agents, Non-Steroidal</term><term>Colchicine</term><term>Dapsone</term><term>Gout Suppressants</term><term>Prednisone</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Jambe</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Polyarteritis Nodosa</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Polyarteritis Nodosa</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Polyartérite noueuse</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphedema</term><term>Polyarteritis Nodosa</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Leg</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lymphoedème</term><term>Polyartérite noueuse</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires</term><term>Anti-inflammatoires non stéroïdiens</term><term>Antigoutteux</term><term>Colchicine</term><term>Dapsone</term><term>Prednisone</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Prognosis</term><term>Recurrence</term><term>Remission, Spontaneous</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Diagnostic différentiel</term><term>Femelle</term><term>Humains</term><term>Polyartérite noueuse</term><term>Pronostic</term><term>Récidive</term><term>Rémission spontanée</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cutaneous periarteritis nodosa is a localized form middle-sized arteriolitis. Its main clinical features are nodules, livedo reticularis and ulcers of the lower limbs.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15639327</PMID><DateCreated><Year>2005</Year><Month>01</Month><Day>10</Day></DateCreated><DateCompleted><Year>2005</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0248-8663</ISSN><JournalIssue CitedMedium="Print"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2005</Year><Month>Jan</Month></PubDate></JournalIssue><Title>La Revue de medecine interne</Title><ISOAbbreviation>Rev Med Interne</ISOAbbreviation></Journal><ArticleTitle>[Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa].</ArticleTitle><Pagination><MedlinePgn>58-60</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Cutaneous periarteritis nodosa is a localized form middle-sized arteriolitis. Its main clinical features are nodules, livedo reticularis and ulcers of the lower limbs.</AbstractText><AbstractText Label="EXEGESIS" NlmCategory="METHODS">We reported a 45 year-old woman with distal lower limb lymphedema. Lymphedema initially spontaneously remitted but recurred nine months after, accompanied with nodules. Cutaneous periarteritis nodosa was diagnosed on histological findings and absence of extracutaneous manifestations. Lymphoscintigraphy showed functional lymphatic insufficiency. Treatment consisted of prednisone followed by colchicine and dapsone. After six months of follow-up, patient remained symptom-free.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We report the first case of lower limb lymphedema associated with cutaneous periarteritis nodosa. Parallel course and unusual corticosensivity of lymphedema and nodules raised the problem of their non coincidental association.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vignes</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unité de Lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris, France. stephane.vignes@hopital-cognacq-jay.fr </Affiliation> </AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoyanova</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Vasseur</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Haicault de la Regontais</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Hanslik</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Lymphoedème réversible des membres inférieurs précédant le diagnostic de périartérite noueuse cutanée pure.</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Rev Med Interne</MedlineTA><NlmUniqueID>8101383</NlmUniqueID><ISSNLinking>0248-8663</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006074">Gout Suppressants</NameOfSubstance></Chemical><Chemical><RegistryNumber>8W5C518302</RegistryNumber><NameOfSubstance UI="D003622">Dapsone</NameOfSubstance></Chemical><Chemical><RegistryNumber>SML2Y3J35T</RegistryNumber><NameOfSubstance UI="D003078">Colchicine</NameOfSubstance></Chemical><Chemical><RegistryNumber>VB0R961HZT</RegistryNumber><NameOfSubstance UI="D011241">Prednisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003078" MajorTopicYN="N">Colchicine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003622" MajorTopicYN="N">Dapsone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006074" MajorTopicYN="N">Gout Suppressants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010488" MajorTopicYN="N">Polyarteritis Nodosa</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012075" MajorTopicYN="N">Remission, Spontaneous</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>06</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>09</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>1</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>3</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>1</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15639327</ArticleId><ArticleId IdType="pii">S0248-8663(04)00366-2</ArticleId><ArticleId IdType="doi">10.1016/j.revmed.2004.09.019</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><noCountry><name sortKey="Haicault De La Regontais, G" sort="Haicault De La Regontais, G" uniqKey="Haicault De La Regontais G" first="G" last="Haicault De La Regontais">G. Haicault De La Regontais</name><name sortKey="Hanslik, T" sort="Hanslik, T" uniqKey="Hanslik T" first="T" last="Hanslik">T. Hanslik</name><name sortKey="Stoyanova, M" sort="Stoyanova, M" uniqKey="Stoyanova M" first="M" last="Stoyanova">M. Stoyanova</name><name sortKey="Vasseur, E" sort="Vasseur, E" uniqKey="Vasseur E" first="E" last="Vasseur">E. Vasseur</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Vignes, S" sort="Vignes, S" uniqKey="Vignes S" first="S" last="Vignes">S. Vignes</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C73 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001C73 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:15639327
|texte= [Reversible lower limb lymphedema as the first manifestation of cutaneous periarteritis nodosa].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:15639327" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |